Omega-3-acid ethyl ester medicines - Important Safety Information from Clonmel Healthcare Ltd. and Basf AS as approved by the HPRA (08.11.23)

Notice type: 3rd Party Publications

Date: 08/11/2023

Problem Or Issue:

Important Safety Information from Clonmel Healthcare Ltd. and Basf AS regarding Omega-3-acid ethyl ester medicines: dose-dependent increased risk of atrial fibrillation in patients with established cardiovascular diseases or cardiovascular risk factors


Important Safety Information – Omega-3-acid ethyl ester medicines

« Back